Redhill Biopharma RDHL Q2 2022 Earnings Massive EPS Miss Raises Liquidity Concerns LITB Q4 2024 Earnings Reports Positive EPS Amid Limited Disclosure KW Q1 2026 Earnings Strong EPS Surprise Amidst Challenging Market TBPH Q1 2026 Earnings Narrower Loss Buoys Investor Sentiment Despite Zero Revenue CTMX Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues DXR Q3 2007 Earnings Stunning Earnings Beat Driven by NonOperating Income